Analysis of the balance regulation mechanism of Montelukast on Th1/Th2 cell function of peripheral blood in asthmatic children
Cao Wei-fang
Abstract
Cao Wei-fang
Abstract
Objective:To investigate the clinical efficacy of Montelukast and to explore its balance regulation mechanism of Montelukast on Th1/Th2 cell function of peripheral blood in asthmatic children.Methods:78 cases of children with bronchial asthma were randomly divided into treatment group and control group in our hospital from December 2008 to December 2010,39 cases in each group.Oxygen uptake,relieving asthma,anti-inflammatory,anti-infection and other basic treatment were given to both groups,thus Montelukast tablets 4 mg/d,orally,once a day for three months were given to the treatment group on the basis of basic treatment.IL-4,IFN-γ levels and IFN-γ/IL-4 ratio changes before and after 3 months treatment were compared,the total efficiency of the two groups were compared,and the disappearance time of cough,asthma and wheezing sound were observed in the two groups.Results:The IFN-γ level of treatment group [(41.45±6.61) ng/L] was significantly higher than that of control group [(46.57±7.42) ng/L](t=2.42,P0.05);the IL-4 level of treatment group [(41.45±6.61) ng/L] was significantly lower than that of control group [(46.57±7.42)ng/L](t=2.68,P0.05);the IFN-γ/IL-4 ratio of treatment group(1.83±0.42) was significantly increased than that of control group(1.56±0.37)(t=2.13,P0.05).The total effective rate of treatment group was 92.31%,and the total efficiency of control group was 74.36%,the difference was statistically significant(χ2=12.537,P0.01).The disappearance time of cough,asthma and wheezing sound of treatment group [(2.68±1.15),(5.19±1.25),(4.17±1.75) d)] were significantly shorter than those of control group [(4.43±1.27),(6.70±1.63),(6.25±1.64) d](t=2.35,2.14,2.41,P0.01).Conclusion:Montelukast in the treatment of patients with bronchial asthma is effective and safe,which can significantly improve the clinical symptoms and signs.The mechanism may relate to the balance regulation of Th1/Th2 cell function in children with asthma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the clinical efficacy of Montelukast and to explore its balance regulation mechanism of Montelukast on Th1/Th2 cell function of peripheral blood in asthmatic children.Methods:78 cases of children with bronchial asthma were randomly divided into treatment group and control group in our hospital from December 2008 to December 2010,39 cases in each group.Oxygen uptake,relieving asthma,anti-inflammatory,anti-infection and other basic treatment were given to both groups,thus Montelukast tablets 4 mg/d,orally,once a day for three months were given to the treatment group on the basis of basic treatment.IL-4,IFN-γ levels and IFN-γ/IL-4 ratio changes before and after 3 months treatment were compared,the total efficiency of the two groups were compared,and the disappearance time of cough,asthma and wheezing sound were observed in the two groups.Results:The IFN-γ level of treatment group [(41.45±6.61) ng/L] was significantly higher than that of control group [(46.57±7.42) ng/L](t=2.42,P0.05);the IL-4 level of treatment group [(41.45±6.61) ng/L] was significantly lower than that of control group [(46.57±7.42)ng/L](t=2.68,P0.05);the IFN-γ/IL-4 ratio of treatment group(1.83±0.42) was significantly increased than that of control group(1.56±0.37)(t=2.13,P0.05).The total effective rate of treatment group was 92.31%,and the total efficiency of control group was 74.36%,the difference was statistically significant(χ2=12.537,P0.01).The disappearance time of cough,asthma and wheezing sound of treatment group [(2.68±1.15),(5.19±1.25),(4.17±1.75) d)] were significantly shorter than those of control group [(4.43±1.27),(6.70±1.63),(6.25±1.64) d](t=2.35,2.14,2.41,P0.01).Conclusion:Montelukast in the treatment of patients with bronchial asthma is effective and safe,which can significantly improve the clinical symptoms and signs.The mechanism may relate to the balance regulation of Th1/Th2 cell function in children with asthma.
Key concepts: Medicine, Montelukast, Asthma, Peripheral blood, Internal medicine, Gastroenterology, Treatment and control groups, Immunology